Header Logo

Connection

DON LYNN GIBBONS to Dasatinib

Back to Details
This is a "connection" page, showing publications DON LYNN GIBBONS has written about Dasatinib.
DON LYNN GIBBONS
Connection Strength
0.021
Dasatinib
  1. Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments. Mol Oncol. 2013 Oct; 7(5):968-75.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.